CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03967951

Title field or adapter rule

{'original_value': 'CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:25.149714+00:00

Published At

2026-09-23T00:00:00+00:00

Record Updated At

2026-09-23

Source Retrieved At

2026-10-31T22:17:54.613222+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Neuroendocrine Tumor"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-23", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT03967951"

protocolSection.identificationModule.officialTitle

"CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

null

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'description': 'Radiomic features will be calculated and extracted from all contrast and non-contrast CT-scans. First order features will be evaluated and high order features will be grouped in parent matrices. Parent matrices of second and third order will be chosen and evaluated.\n\nIn the second part, based on the results of inter-correlation of the operator analysis, the most significant radiomic features will be chosen. Morphological and histopathological features will be evaluated will be.\n\nHistopathology will be performed on a biopsy specimen; percentage of Ki67 and grading will be evaluated.', 'name': 'CT radiomic feature evaluation', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.